Возраст домена | 16 лет |
Дата окончания | Истек срок регистрации |
PR | 4 |
ИКС | n/a |
Страниц в Google | 633 |
Страниц в Яндексе | 7 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 8901746 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Cancer Drug Pipeline Information for Patient Advocacy Groups |
n/a
n/a
UTF-8
211.26 КБ
2 500
52 359 симв.
46 389 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
cancer.ca | 7 | 7 |
0 | 52589 | 2961 | |
ccra-acrc.ca | 2 | 4 |
0 | 6654145 | Нет данных | |
facebook.com | 1 | 9 |
0 | 3 | 3 | |
convio.net | 1 | 8 |
50 | 19008 | 4313 | |
cancerconnection.ca | 1 | 5 |
0 | 1374126 | 33898 | |
canadiancancertrials.ca | 1 | 5 |
0 | 1958553 | Нет данных | |
bccancerfoundation.com | 1 | 5 |
0 | 1276965 | 51539 | |
3ctn.ca | 1 | 3 |
0 | 14536572 | Нет данных | |
Еще 9 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 3 Ноября 2014 ) | |
Количество ссылок на сайт | 398 |
Количество доменов, которые ссылаются на сайт | 28 |
Количество найденных анкоров | 16 |
Исходящие (внешние) ссылки домена | 13447 |
Количество доменов, на которые ссылается сайт | 117 |
Количество исходящих анкоров | 139 |
Внешние ссылки главной страницы ( 96 ) | |
ab-science.com/pipeline/masitinib nofollow | http://www.ab-science.com/pipeline/masitinib |
abbvie.com/our-science/pipeline.html nofollow | https://www.abbvie.com/our-science/pipeline.html |
amgentrials.com/amgen/studysearch.aspx?SearchStr=talimogene+... nofollow | http://www.amgentrials.com/amgen/studysearch.aspx?SearchStr=talimogene+laherparepvec |
wayback.archive-it.org/7993/20170111064250/fda.gov/Drugs/Inf... nofollow | http://wayback.archive-it.org/7993/20170111064250/http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm279174.htm |
amgenpipeline.com/pipeline/ nofollow | http://www.amgenpipeline.com/pipeline/ |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm611981.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm611981.htm |
arraybiopharma.com/product-pipeline/encorafenib-lgx818/ nofollow | http://www.arraybiopharma.com/product-pipeline/encorafenib-lgx818/ |
arraybiopharma.com/product-pipeline/binimetinib/ nofollow | http://www.arraybiopharma.com/product-pipeline/binimetinib/ |
astellas.com/jp/en/investors/ir-library/pipeline nofollow | https://www.astellas.com/jp/en/investors/ir-library/pipeline |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm627045.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm627045.htm |
astrazeneca.com/our-focus-areas/oncology.html nofollow | https://www.astrazeneca.com/our-focus-areas/oncology.html |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm620473.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm620473.htm |
fda.gov/drugs/resources-information-approved-drugs/fda-appro... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-darolutamide-non-metastatic-castration-resistant-pro... |
pharma.bayer.com/en/innovation-partnering/development-pipeli... nofollow | http://pharma.bayer.com/en/innovation-partnering/development-pipeline/ |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm576098.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm576098.htm |
inoncology.com/our-compounds nofollow | https://www.inoncology.com/our-compounds |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm569366.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm569366.htm |
celgene.com/research-development/ nofollow | https://www.celgene.com/research-development/ |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm355438.htm nofollow | http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm355438.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm533891.htm nofollow | http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm533891.htm |
eisai.com/pdf/eir/erepo/epipeline.pdf nofollow | http://www.eisai.com/pdf/eir/erepo/epipeline.pdf |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm483795.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm483795.htm |
wayback.archive-it.org/7993/20170111231635/fda.gov/Drugs/Inf... nofollow | http://wayback.archive-it.org/7993/20170111231635/http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm444496.htm |
lillyoncologypipeline.com/clinical-phase/II nofollow | http://lillyoncologypipeline.com/clinical-phase/II |
fda.gov/drugs/resources-information-approved-drugs/fda-appro... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-ramucirumab-hepatocellular-carcinoma |
wayback.archive-it.org/7993/20170111064250/fda.gov/Drugs/Inf... nofollow | http://wayback.archive-it.org/7993/20170111064250/http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm426735.htm |
lillyoncologypipeline.com/assets/cms/molecule_flashcards/pip... nofollow | http://lillyoncologypipeline.com/assets/cms/molecule_flashcards/pipeline_brochure.pdf |
lillyoncologypipeline.com/molecule/cdk-4-and-cdk-6-inhibitor... nofollow | http://lillyoncologypipeline.com/molecule/cdk-4-and-cdk-6-inhibitor/trials |
emdgroup.com/en/research/biopharma-pipeline.html?_ga=2.19454... nofollow | https://www.emdgroup.com/en/research/biopharma-pipeline.html?_ga=2.1945463.75812796.1559521939-1503451630.1517146188 |
fda.gov/drugs/resources-information-approved-drugs/fda-appro... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-avelumab-plus-axitinib-renal-cell-carcinoma |
exelixis.com/cabozantinib-development-program/ nofollow | https://www.exelixis.com/cabozantinib-development-program/ |
gene.com/medical-professionals/pipeline nofollow | https://www.gene.com/medical-professionals/pipeline |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm501878.htm nofollow | http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm501878.htm |
roche.com/research_and_development/who_we_are_how_we_work/pi... nofollow | https://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm626499.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm626499.htm |
fda.gov/drugs/resources-information-approved-drugs/fda-appro... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-ado-trastuzumab-emtansine-early-breast-cancer |
fda.gov/drugs/resources-information-approved-drugs/fda-appro... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-daratumumab-multiple-myeloma-ineligible-autologous-s... |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm627874.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm627874.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm633814.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm633814.htm |
janssen.com/research-and-development/product-pipeline nofollow | http://www.janssen.com/research-and-development/product-pipeline |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm569950.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm569950.htm |
fda.gov/drugs/resources-information-approved-drugs/fda-appro... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-advanced-esophageal-squamous-cell-canc... |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm577093.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm577093.htm |
merck.com/research/pipeline/home.html nofollow | https://www.merck.com/research/pipeline/home.html |
fda.gov/drugs/drug-approvals-and-databases/fda-approves-pemb... nofollow | https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-pembrolizumab-plus-axitinib-advanced-renal-cell-carcinoma |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm515627.htm nofollow | http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm515627.htm |
wayback.archive-it.org/7993/20170111231633/fda.gov/Drugs/Inf... nofollow | http://wayback.archive-it.org/7993/20170111231633/http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm455865.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm435339.htm nofollow | http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm435339.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm279174.htm nofollow | http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm279174.htm |
novartis.com/our-company/novartis-oncology nofollow | https://www.novartis.com/our-company/novartis-oncology |
fda.gov/drugs/resources-information-approved-drugs/hematolog... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/hematologyoncology-cancer-approvals-safety-notifications |
pfizer.com/science/drug-product-pipeline nofollow | https://www.pfizer.com/science/drug-product-pipeline |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm585686.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm585686.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm574518.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm574518.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm490391.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm490391.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm589856.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm589856.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm567259.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm567259.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm622251.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm622251.htm |
sanofigenzyme.com/en/products-research/research-pipeline nofollow | https://www.sanofigenzyme.com/en/products-research/research-pipeline |
seattlegenetics.com/pipeline nofollow | http://www.seattlegenetics.com/pipeline |
takeda.com/siteassets/system/what-we-do/research-and-develop... nofollow | https://www.takeda.com/siteassets/system/what-we-do/research-and-development-rd-in-takeda/our-pipeline/pipeline_en_q4.pdf |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm548487.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm548487.htm |
gilead.com/research/pipeline nofollow | http://www.gilead.com/research/pipeline |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm581296.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm581296.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm589842.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm589842.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm629512.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm629512.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm584543.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm584543.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm583106.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm583106.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm601947.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm601947.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm596015.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm596015.htm |
ipsen.com/research-development/pipeline/ nofollow | https://www.ipsen.com/research-development/pipeline/ |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm603171.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm603171.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm606708.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm606708.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm610572.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm610572.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm610664.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm610664.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm614128.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm614128.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm615157.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm615157.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm617370.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm617370.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm621503.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm621503.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm623540.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm623540.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm625705.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm625705.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm629090.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm629090.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm628980.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm628980.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm628867.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm628867.htm |
fda.gov/drugs/resources-information-approved-drugs/fda-appro... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-polatuzumab-vedotin-piiq-diffuse-large-b-cell-lympho... |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm633065.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm633065.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm632294.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm632294.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm632032.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm632032.htm |
fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm631565.htm nofollow | https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm631565.htm |
fda.gov/drugs/fda-expands-pembrolizumab-indication-first-lin... nofollow | https://www.fda.gov/drugs/fda-expands-pembrolizumab-indication-first-line-treatment-nsclc-tps-1 |
fda.gov/drugs/resources-information-approved-drugs/fda-appro... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lenalidomide-follicular-and-marginal-zone-lymphoma |
fda.gov/drugs/resources-information-approved-drugs/fda-grant... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-selinexor-multiple-myeloma |
fda.gov/drugs/resources-information-approved-drugs/fda-appro... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-metastatic-small-cell-lung-cancer |
fda.gov/drugs/resources-information-approved-drugs/fda-appro... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-first-line-treatment-head-and-neck-squ... |
fda.gov/drugs/resources-information-approved-drugs/fda-appro... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pexidartinib-tenosynovial-giant-cell-tumor |
fda.gov/drugs/resources-information-approved-drugs/fda-appro... nofollow | https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-entrectinib-ntrk-solid-tumors-and-ros-1-nsclc |
Внутренние ссылки главной страницы ( 2 ) | |
# | |
ccanceraction.ca/feed/ | RSS |
Domain name: ccanceraction.ca
Domain status: registered
Creation date: 2007/10/30
Expiry date: 2019/10/30
Updated date: 2018/10/07
Registrar:
Name: Netfirms, LTD
Number: 150
Name servers:
dns1.easydns.com
dns2.easydns.net
User-agent: *
Disallow: /wp-admin/
Allow: /wp-admin/admin-ajax.php
HTTP/1.1 200 OK
Date: Wed, 16 Oct 2019 03:03:23 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Vary: Accept-Encoding
Server: Pagely-ARES/1.4.10
X-Pingback: http://www.ccanceraction.ca/xmlrpc.php
Link: ; rel="https://api.w.org/", ; rel=shortlink
Vary: Accept-Encoding
X-Gateway-Cache-Key: 1567858254.075|standard|http|www.ccanceraction.ca||/
X-Gateway-Cache-Status: MISS
X-Gateway-Skip-Cache: 0
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"